Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material
CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Cardiac Patch Material
CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
CryoLife Reports Record Quarterly Revenues of $28.2 Million
CryoLife Announces Release Date and Teleconference Call Details for 2009 Second Quarter Financial Results
BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
CryoLife Reports Record First Quarter Revenues of $26.7 Million
CryoLife Announces Release Date and Teleconference Call Details for 2009 First Quarter Financial Results
Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology
CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum
CryoLife Reports Record Annual Revenues of $105.1 Million for FY 2008
FDA Clears New Immune Response Claim for the CryoValve(R) SG Pulmonary Human Heart Valve
CryoLife Announces Release Date and Teleconference Call Details for 2008 Fourth Quarter and Year End Financial Results
CryoLife, Inc. Receives Tissue From 100,000th Donor, Marking Industry Milestone
CryoLife to Present at 20th Annual Piper Jaffray Health Care Conference
CryoLife's Fully Diluted Earnings Per Share Increased 71 Percent to $0.12 in Third quarter of 2008 from $0.07 in Third quarter of 2007
CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2008 Financial Results
CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure
CryoLife Expands Distribution of Hemostase MPH(R) to Canada through Sorin Group Canada, Inc.
CryoLife to Present at UBS Global Life Sciences Conference
CryoLife Expands Distribution of Hemostase MPH(R) to France through Laboratoire Gamida
CryoLife Announces Management Promotions
CryoLife's Earnings Per Share Increased 180 Percent to $0.14 in Second Quarter of 2008 from $0.05 in Second Quarter of 2007
CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2008 Financial Results
Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery
Wall Street Media Presents Three Exclusive Video Clips from the 2008 FBR Capital Markets Conference
CryoLife to Present at FBR Capital Markets Annual Spring Investor Conference
CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic - Jun 1 2008 4:54PM
Harvey Morgan Joins CryoLife Board of Directors - Jun 1 2008 4:53PM
CryoLife's Earnings Per Share Increases 150 Percent to $0.10 in First Quarter of 2008 from $0.04 in First Quarter of 2007
CryoLife Conducts Surgeons Cardiac Allograft Symposium
CryoLife to Distribute FDA-approved Hemostatic Agent Under Private Label
CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results
William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
